Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00311610
What this trial is testing

Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 30
Large-scale testing (Phase 3)Study completedNCT00025337
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 880
Testing effectiveness (Phase 2)Study completedNCT00326495
What this trial is testing

BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Ended earlyNCT00816777
What this trial is testing

Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colo-rectal Cancer
Generic Devices Consulting, Inc. 4
Testing effectiveness (Phase 2)Looking for participantsNCT05806931
What this trial is testing

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Testing effectiveness (Phase 2)Study completedNCT00113776
What this trial is testing

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

Who this might be right for
Colorectal Cancer
Amgen
Testing effectiveness (Phase 2)Study completedNCT00235898
What this trial is testing

Clinical Trial in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Mast Therapeutics, Inc. 300
Large-scale testing (Phase 3)Ended earlyNCT01437514
What this trial is testing

Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer

Who this might be right for
Rectal Neoplasms
West China Hospital 410
Testing effectiveness (Phase 2)Study completedNCT00028015
What this trial is testing

SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
NCIC Clinical Trials Group 18
Testing effectiveness (Phase 2)Study completedNCT00544349
What this trial is testing

Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Gustave Roussy, Cancer Campus, Grand Paris 45
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Early research (Phase 1)Ended earlyNCT00049608
What this trial is testing

Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
National Center for Complementary and Integrative Health (NCCIH) 51
Testing effectiveness (Phase 2)WithdrawnNCT02287727
What this trial is testing

Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment

Who this might be right for
Rectal AdenocarcinomaStage IIA Rectal CancerStage IIB Rectal Cancer+3 more
Roswell Park Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00952029
What this trial is testing

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 492
Testing effectiveness (Phase 2)Study completedNCT00004187
What this trial is testing

Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute
Early research (Phase 1)UnknownNCT00021268
What this trial is testing

Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00967616
What this trial is testing

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Who this might be right for
Colorectal CancerNeoplasms, Colorectal
Daiichi Sankyo 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178717
What this trial is testing

Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic Colorectal Cancer Patients After Previous Therapy With BRAF Inhibitors-based Combinations

Who this might be right for
Colo-rectal Cancer
Vall d'Hebron Institute of Oncology 25
Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Next Page